Why the study?
Do target specific oral anticoagulants provide effective and safe venous thromboprophylaxis compared to traditional agents in patients undergoing total hip arthroplasty?
Do target specific oral anticoagulants provide effective and safe venous thromboprophylaxis compared to traditional agents in patients undergoing total hip arthroplasty?
Target specific oral anticoagulants offer an effective, safe, and convenient oral alternative to low-molecular weight heparins for venous thromboprophylaxis following total hip arthroplasty.
No takes yet. Share an insight, caveat, or question.
May support TSOAs over LMWH post-THA; confirms phase III data yet leaves optimal agent selection open.
Garrett B. Aikens (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: